DPP4 and triple-A syndrome: Experimental studies were investigating a range of medications such as thiazolidinediones and dipeptidyl peptidase-4 inhibitors [245,246], but metformin seems to be the only drug consistently associated with reduced AAA growth in clinical studies [247].